Skip to content

To explore the clinical effect of family-centered speech therapy on children with language retardation based on the routine-based model

To explore the clinical effect of family-centered speech therapy on children with language retardation based on the routine-based model

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036354
Enrollment
Unknown
Registered
2020-08-22
Start date
2020-08-21
Completion date
Unknown
Last updated
2020-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

language delay

Interventions

trial group:conventional speech therapy intervention in combination with traditional family rehabilitation guidance
control group:conventional speech therapy intervention with the family guidance under the routines-based model standard model.

Sponsors

The Third People's Hospital affiliated to Fujian University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 6 Years

Inclusion criteria

Inclusion criteria: 1. After rigorous diagnosis and evaluation, it meets the diagnostic criteria for language development delay; 2. Aged 1-6 years; 3. The child has no genetic history and family history of language development disorders; 4. Those whose parents agree and can cooperate with treatment for up to 6 months, and who have signed an informed consent form at the same time.

Exclusion criteria

Exclusion criteria: 1. Combined with other mental illnesses; 2. Organ dysfunction; 3. Patients with hearing impairment; 4. Patients with unqualified and incomplete data.

Design outcomes

Primary

MeasureTime frame
Gesell Developmental Schedules;Gesell Developmental Schedules;

Countries

China

Contacts

Public ContactZeng Cuiping

The Third People's Hospital affiliated to Fujian University of Traditional Chinese Medicine

501230351@qq.com+86 18859987587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026